SHL Medical
Manufacturing · Switzerland · 5,000 Employees
SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced delivery devices such as autoinjectors, pen injectors, and wearable drug delivery systems. We offer final assembly, labeling, and packaging solutions for ourdrug delivery devices, and also provide contract manufacturing and engineering services for the production of complex medtech and industrial products.Read More
View Company Info for Free
Who is SHL Medical
Headquarters
Phone Number
Website
Revenue
Industry
SHL Medical Org Chart
SHL Medical Company Metrics
-
Total Funding Amount
-
Most Recent Funding Amount
1
Number of Funding Rounds
Apr 28, 2018
LCA Automation
Jan 24, 2013
Weibel CDS
SHL Group (Scandinavian Health Limited
See More Acquisitions & Subsidiaries
SHL Medical News & Media
SHL Medical acquires 100% of the shares in Swiss company LCA Automation
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider. The acquisition is SHL Medical's response to the growing market demand for drug delivery solutions and will support its manufacturing operations globally, especially the upcoming...SHL Medical acquires 100% of the shares in Swiss company LCA Automation
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider. The acquisition is SHL Medical's response to the growing market demand for drug delivery solutions and will support its manufacturing operations globally, especially the upcoming...Autoinjectors Market 2023: New Changes and Technology, Drivers, and Growth by 2028
Northbrook, IL 60062 -- (SBWIRE) -- 06/22/2023 -- In May 2023, SHL Medical and MoonLake Immunotherapeutics collaborated to develop the sonelokimab autoinjector. SHL Medical's Molly autoinjector technology will be utilized for the clinical and potential commercial supply of MoonLake's Nanobody sonelokimab. Read the full press release at http://www.sbwire.com/press-releases/autoinjectors-market-2023-new-changes-and-technology-drivers-and-growth-by-2028-1375262.htmSHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector
ZUG, Switerland, May 11, 2023 /PRNewswire/ -- SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, to develop an autoinjector for clinical and potential commercial supply of MoonLake's Nanobody® sonelokimab based on SHL Medical's Molly® autoinjector technology. SHL Medical to devel
Frequently Asked Questions regarding SHL Medical
SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced delivery devices such as autoinjectors, pen injectors, and wearable drug delivery systems. We offer final assembly, labeling, and packaging solutions for our drug delivery devices, and also provide contract manufacturing and engineering servi... Read More